2001
DOI: 10.1016/s0002-9343(01)00792-6
|View full text |Cite
|
Sign up to set email alerts
|

Oral cobalamin therapy for the treatment of patients with food-cobalamin malabsorption

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
54
0
5

Year Published

2002
2002
2015
2015

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 82 publications
(65 citation statements)
references
References 15 publications
5
54
0
5
Order By: Relevance
“…However, this dosage regimen has been continuously and markedly decreased in these last years (see or current recommendations in [29], perhaps because absorption by the intrinsic factor-cubilin complex is maintained (for free not-bound cobalamin), and adds to the cobalamin portion that is absorbed by passive diffusion. In one of the studies conducted by the Strasbourg team, patients having received 250 to 500µg/day exhibited favourable biological and clinical responses that were similar in size to those observed with the full dose [31]. A similar observation was later made in several other clinical trials using still lower dose levels [34,36,39].…”
Section: Treatmentmentioning
confidence: 53%
See 3 more Smart Citations
“…However, this dosage regimen has been continuously and markedly decreased in these last years (see or current recommendations in [29], perhaps because absorption by the intrinsic factor-cubilin complex is maintained (for free not-bound cobalamin), and adds to the cobalamin portion that is absorbed by passive diffusion. In one of the studies conducted by the Strasbourg team, patients having received 250 to 500µg/day exhibited favourable biological and clinical responses that were similar in size to those observed with the full dose [31]. A similar observation was later made in several other clinical trials using still lower dose levels [34,36,39].…”
Section: Treatmentmentioning
confidence: 53%
“…We have recently published an exhaustive review of the efficacy of oral cobalamin therapy in reference [29]. Table 3 summarizes the results of various not blinded, placebo-controlled trials that we conducted with oral cyanocobalamin in the context of FCM management [30][31][32]. All of the patients who were treated orally corrected their vitamin B12 levels and at least 80% corrected their hematological abnormalities.…”
Section: Treatmentmentioning
confidence: 99%
See 2 more Smart Citations
“…Le traitement par voie orale permet une amélioration significative du taux sérique de la vitamine B12 et des paramètres hématologiques (taux d'hémoglobine, volume globulaire moyen), aussi bien chez les patients atteints de syndrome de non-dissociation de la vitamine B12 de ses protéines porteuses que chez ceux atteints d'une anémie de Biermer [5,7,15]. Dans une étude portant sur 120 patients, Eussen et al ont cherché à déterminer la dose de vitamine B12 nécessaire per os pour réduire de 80 à 90 % la concentration plasmatique de l'acide méthylmalo-nique.…”
Section: Diagnostic Et Traitement De La Carence En Vitamine B12unclassified